HOME >> MEDICINE >> NEWS
Tip sheet for Annals of Internal Medicine -- May 1, 2007, issue

Two studies in the May 1, 2007, Annals of Internal Medicine find that infliximab, a widely used anti-tumor necrosis drug, has no benefit in patients receiving standard corticosteroid treatment for giant-cell arteritis (GCA) or polymyalgia rheumatica (PMR). The diseases, common overlapping inflammatory rheumatic diseases of unknown origin, are usually treated with steroids, which can have serious side effects if used for long periods at high doses.

In one study, 44 patients being treated with steroids for newly diagnosed GCA were assigned to receive either infliximab or a placebo (Article, p. 621). All patients followed a schedule to gradually reduce the dose of steroid dose. The study, planned to last 54 weeks, was stopped at 22 weeks because it became clear that infliximab did not prevent relapse of symptoms or reduce the amount off steroids needed to reduce the symptoms.

In another study, 51 patients being treated with corticosteroids for newly diagnosed PMR were assigned to receive either infliximab or a placebo (Article, p. 631). At the end of the 22-week study, infliximab had not prevented relapse of symptoms or reduced the dose of steroids.

An editorial writer says that GCA and polymyalgia rheumatica remain therapeutic challenges. For now, steroids remain the standard treatment (Editorial, p. 674).


'"/>

Contact: Susan Anderson
sanderson@acponline.org
215-351-2653
American College of Physicians
30-Apr-2007


Page: 1

Related medicine news :

1. Annals of Internal Medicine tip sheet for Aug. 7, 2007, issue
2. May/June Annals of Family Medicine tip sheet
3. Tip sheet Annals of Internal Medicine, April 17, 2007
4. Embargoed March/April Annals of Family Medicine tip sheet
5. Annals of Internal Medicine tip sheet for March 6, 2007
6. Annals of Internal Medicine tip sheet for Feb. 20, 2007, issue
7. Embargoed Jan./Feb. Annals of Family Medicine tip sheet
8. November/December 2006 Annals of Family Medicine tip sheet
9. Annals of Internal Medicine tip sheet for December 5, 2006
10. Tip sheet Annals of Internal Medicine, Nov. 21, 2006, issue
11. Tipsheet: Focus on gait training, pain relief, pressure ulcers and hearing aid training

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology:
Cached News: